Search

Author/Creator Wilson, Nathaniel R.

12. Outcomes of patients with intermediate‐risk or poor‐risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience. Issue 2 (24th March 2021)

Authors:
Alhalabi, Omar; Hasanov, Elshad; Wilson, Nathaniel R.; Araujo, John; Wang, Jianbo; Campbell, Matthew T.; Goswami, Sangeeta; Shah, Amishi Y.; Gao, Jianjun; Msaouel, Pavlos; Tannir, Nizar M.
Journal:
International journal of cancer
Issue:
Volume 149:Issue 2(2021)
Page Start:
387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation. (25th November 2020)

Authors:
Wilson, Nathaniel R.; Fang, Hong; Loghavi, Sanam; Wang, Wei; Tang, Guilin; Haltom, Rodney O.; Rausch, Caitlin R.; McClain, Kenneth L.; Rao, Koneti V.; Popat, Uday R.; Fayad, Luis E.; Champa, Naly; Calvo, Katherine R.; Allen, Carl E.; Kadia, Tapan M.; Pemmaraju, Naveen
Journal:
British journal of haematology
Issue:
Volume 192:Number 3(2021)
Page Start:
667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗